{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:06:40Z","timestamp":1794431200569,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","award":["M202010"],"award-info":[{"award-number":["M202010"]}],"id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016308","name":"Wuxi Health and Family Planning Commission","doi-asserted-by":"publisher","award":["M202010"],"award-info":[{"award-number":["M202010"]}],"id":[{"id":"10.13039\/501100016308","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06853-w","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:30:20Z","timestamp":1747038620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlations between major depressive disorder, splenic morphology, and immune function"],"prefix":"10.1186","volume":"25","author":[{"given":"Zouqing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"6853_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2018.08.010","volume":"74","author":"R Dantzer","year":"2018","unstructured":"Dantzer R, Cohen S, Russo SJ, Dinan TG. Resilience and immunity. Brain Behav Immun. 2018;74:28\u201342.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"6853_CR2","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/sj.npp.1301649","volume":"33","author":"JP Godbout","year":"2008","unstructured":"Godbout JP, Moreau M, Lestage J, Chen J, Sparkman NL, O\u2019Connor J, et al. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology. 2008;33(10):2341\u201351.","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"6853_CR3","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732\u201341.","journal-title":"Biol Psychiatry"},{"key":"6853_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-244X-12-2","volume":"12","author":"A-P Elomaa","year":"2012","unstructured":"Elomaa A-P, Niskanen L, Herzig K-H, Viinam\u00e4ki H, Hintikka J, Koivumaa-Honkanen H, et al. Elevated levels of serum IL-5 are associated with an increased likelihood of major depressive disorder. BMC Psychiatry. 2012;12:2.","journal-title":"BMC Psychiatry"},{"key":"6853_CR5","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","volume":"64","author":"YK Kim","year":"2016","unstructured":"Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:277\u201384.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"664","key":"6853_CR6","doi-asserted-by":"publisher","first-page":"eabq3059","DOI":"10.1126\/scitranslmed.abq3059","volume":"14","author":"JJ Frere","year":"2022","unstructured":"Frere JJ, Serafini RA, Pryce KD, Zazhytska M, Oishi K, Golynker I, et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022;14(664):eabq3059.","journal-title":"Sci Transl Med"},{"issue":"11","key":"6853_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.biopsych.2004.02.009","volume":"56","author":"L Capuron","year":"2004","unstructured":"Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry. 2004;56(11):819\u201324.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"6853_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/brbi.2001.0654","volume":"16","author":"M Irwin","year":"2002","unstructured":"Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav Immun. 2002;16(1):1\u201316.","journal-title":"Brain Behav Immun"},{"key":"6853_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jad.2015.04.044","volume":"182","author":"HK Al-Hakeim","year":"2015","unstructured":"Al-Hakeim HK, Al-Rammahi DA, Al-Dujaili AH. IL-6, IL-18, sIL-2R, and TNFalpha proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation. J Affect Disord. 2015;182:106\u201314.","journal-title":"J Affect Disord"},{"issue":"1","key":"6853_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41398-019-0521-7","volume":"9","author":"L Carboni","year":"2019","unstructured":"Carboni L, McCarthy DJ, Delafont B, Filosi M, Ivanchenko E, Ratti E, et al. Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies. Transl Psychiatry. 2019;9(1):182.","journal-title":"Transl Psychiatry"},{"key":"6853_CR11","doi-asserted-by":"publisher","first-page":"107480","DOI":"10.1016\/j.pharmthera.2020.107480","volume":"208","author":"SW Mok","year":"2020","unstructured":"Mok SW, Wong VK, Lo HH, de Seabra Rodrigues Dias IR, Leung EL, Law BY, et al. Natural products-based polypharmacological modulation of the peripheral immune system for the treatment of neuropsychiatric disorders. Pharmacol Ther. 2020;208:107480.","journal-title":"Pharmacol Ther."},{"issue":"12","key":"6853_CR12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2013.11.029","volume":"75","author":"ES Wohleb","year":"2014","unstructured":"Wohleb ES, McKim DB, Shea DT, Powell ND, Tarr AJ, Sheridan JF, et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry. 2014;75(12):970\u201381.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"6853_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbr.2011.07.006","volume":"225","author":"Z You","year":"2011","unstructured":"You Z, Luo C, Zhang W, Chen Y, He J, Zhao Q, et al. Pro- and anti-inflammatory cytokines expression in rat\u2019s brain and spleen exposed to chronic mild stress: involvement in depression. Behav Brain Res. 2011;225(1):135\u201341.","journal-title":"Behav Brain Res"},{"key":"6853_CR14","doi-asserted-by":"publisher","first-page":"113935","DOI":"10.1016\/j.bcp.2020.113935","volume":"177","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto K. Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol. 2020;177: 113935.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"6853_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00406-019-01092-z","volume":"271","author":"K Zhang","year":"2021","unstructured":"Zhang K, Sakamoto A, Chang L, Qu Y, Wang S, Pu Y, et al. Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine. Eur Arch Psychiatry Clin Neurosci. 2021;271(3):447\u201356.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"6853_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.yexmp.2017.06.010","volume":"103","author":"K Vadstrup","year":"2017","unstructured":"Vadstrup K, Galsgaard ED, Jensen H, Lanier LL, Ryan JC, Chen SY, et al. NKG2D ligand expression in Crohn\u2019s disease and NKG2D-dependent stimulation of CD8(+) T cell migration. Exp Mol Pathol. 2017;103(1):56\u201370.","journal-title":"Exp Mol Pathol"},{"issue":"8","key":"6853_CR17","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jop.13185","volume":"50","author":"M Ivanova","year":"2021","unstructured":"Ivanova M, Al Hadra B, Yordanov S, Lesichkova S, Stoyanov H, Shivarov V, et al. Associations of high-resolution-typing-defined MICA and MICB polymorphisms, and the levels of soluble MICA and MICB with Oral Squamous Cell Carcinoma in Bulgarian patients. J Oral Pathol Med. 2021;50(8):758\u201365.","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"6853_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.it.2008.04.007","volume":"29","author":"S Gonzalez","year":"2008","unstructured":"Gonzalez S, Lopez-Soto A, Suarez-Alvarez B, Lopez-Vazquez A, Lopez-Larrea C. NKG2D ligands: key targets of the immune response. Trends Immunol. 2008;29(8):397\u2013403.","journal-title":"Trends Immunol"},{"key":"6853_CR19","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fimmu.2018.00476","volume":"9","author":"A Zingoni","year":"2018","unstructured":"Zingoni A, Molfetta R, Fionda C, Soriani A, Paolini R, Cippitelli M, et al. NKG2D and Its Ligands: \u201cOne for All, All for One.\u201d Front Immunol. 2018;9:476.","journal-title":"Front Immunol"},{"key":"6853_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3389\/fimmu.2018.01219","volume":"9","author":"M Babic","year":"2018","unstructured":"Babic M, Romagnani C. The Role of Natural Killer Group 2, Member D in Chronic Inflammation and Autoimmunity. Front Immunol. 2018;9:1219.","journal-title":"Front Immunol"},{"key":"6853_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W, Jung H. Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol. 2013;31:413\u201341.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"6853_CR22","doi-asserted-by":"publisher","first-page":"e20190133","DOI":"10.1084\/jem.20190133","volume":"217","author":"M Babic","year":"2020","unstructured":"Babic M, Dimitropoulos C, Hammer Q, Stehle C, Heinrich F, Sarsenbayeva A, et al. NK cell receptor NKG2D enforces proinflammatory features and pathogenicity of Th1 and Th17 cells. J Exp Med. 2020;217(8):e20190133.","journal-title":"J Exp Med."},{"issue":"6","key":"6853_CR23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/tan.13434","volume":"92","author":"ST Cox","year":"2018","unstructured":"Cox ST, Hernandez D, Danby R, Turner TR, Madrigal JA. Diversity and characterisation of polymorphic 3\u2019 untranslated region haplotypes of MICA and MICB genes. HLA. 2018;92(6):392\u2013402.","journal-title":"HLA"},{"issue":"10","key":"6853_CR24","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170(10):1134\u201342.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"6853_CR25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","volume":"47","author":"RM Berman","year":"2000","unstructured":"Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000;47(4):351\u20134.","journal-title":"Biol Psychiatry."},{"issue":"4","key":"6853_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","volume":"74","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, Aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74(4):250\u20136.","journal-title":"Biol Psychiatry."},{"issue":"4","key":"6853_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA, Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of \u03b1-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors. Biol Psychiat. 2008;63(4):349\u201352.","journal-title":"Biol Psychiat"},{"key":"6853_CR28","doi-asserted-by":"crossref","unstructured":"Xu Y, Hackett M, Carter G, Loo C, G\u00e1lvez V, Glozier N, et al. Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis. Int J Neuropsychopharmacol. 2016;19(4).","DOI":"10.1093\/ijnp\/pyv124"},{"key":"6853_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jad.2019.11.086","volume":"264","author":"FS Correia-Melo","year":"2020","unstructured":"Correia-Melo FS, Leal GC, Vieira F, Jesus-Nunes AP, Mello RP, Magnavita G, et al. Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study. J Affect Disord. 2020;264:527\u201334.","journal-title":"J Affect Disord"},{"issue":"1","key":"6853_CR30","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41398-024-02738-w","volume":"14","author":"RL Sumner","year":"2024","unstructured":"Sumner RL, McMillan RL, Forsyth A, Muthukumaraswamy SD, Shaw AD. Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine. Transl Psychiatry. 2024;14(1):116.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"6853_CR31","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.biopsych.2013.02.008","volume":"73","author":"PJ Carlson","year":"2013","unstructured":"Carlson PJ, Diazgranados N, Nugent AC, Ibrahim L, Luckenbaugh DA, Brutsche N, et al. Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study. Biol Psychiat. 2013;73(12):1213\u201321.","journal-title":"Biol Psychiat"},{"issue":"12","key":"6853_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014","volume":"76","author":"P Belujon","year":"2014","unstructured":"Belujon P, Grace AA. Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity. Biol Psychiat. 2014;76(12):927\u201336.","journal-title":"Biol Psychiat"},{"key":"6853_CR33","doi-asserted-by":"publisher","first-page":"1388946","DOI":"10.3389\/fpsyt.2024.1388946","volume":"15","author":"H Chen","year":"2024","unstructured":"Chen H, Zhao X, Ma X, Ma H, Zhou C, Zhang Y, et al. Effects of esketamine and fluoxetine on depression-like behaviors in chronic variable stress: a role of plasma inflammatory factors. Front Psychiatry. 2024;15:1388946.","journal-title":"Front Psychiatry"},{"issue":"9","key":"6853_CR34","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1038\/s41380-024-02507-7","volume":"29","author":"B Quintanilla","year":"2024","unstructured":"Quintanilla B, Zarate CA Jr, Pillai A. Ketamine\u2019s mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine\u2019s antidepressant effects? Mol Psychiatry. 2024;29(9):2849\u201358.","journal-title":"Mol Psychiatry."},{"issue":"1","key":"6853_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3892\/mi.2023.67","volume":"3","author":"SM Fateh","year":"2023","unstructured":"Fateh SM, Mohammed NA, Mahmood KA, Hasan \u0391H, Tahir SH, Kakamad FH, et al. Sonographic measurement of splenic size and its correlation with body parameters. Med Int. 2023;3(1):7.","journal-title":"Med Int"},{"issue":"72","key":"6853_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.15557\/JoU.2018.0001","volume":"18","author":"M \u00d6zdikici","year":"2018","unstructured":"\u00d6zdikici M. The relationship between splenic length in healthy children from the Eastern Anatolia Region and sex, age, body height and weight. Journal of ultrasonography. 2018;18(72):5\u20138.","journal-title":"Journal of ultrasonography"},{"issue":"2","key":"6853_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/YCT.0b013e3181b00f32","volume":"26","author":"M Okazaki","year":"2010","unstructured":"Okazaki M, Tominaga K, Higuchi H, Utagawa I, Nakamura E, Noguchi M, et al. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients. J ect. 2010;26(2):87\u201390.","journal-title":"J ect."},{"key":"6853_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jad.2020.12.119","volume":"282","author":"NB Rodrigues","year":"2021","unstructured":"Rodrigues NB, McIntyre RS, Lipsitz O, Lee Y, Cha DS, Shekotikhina M, et al. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions. J Affect Disord. 2021;282:160\u20134.","journal-title":"J Affect Disord"},{"key":"6853_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/B978-0-444-52002-9.00013-9","volume":"106","author":"D Maust","year":"2012","unstructured":"Maust D, Cristancho M, Gray L, Rushing S, Tjoa C, Thase ME. Psychiatric rating scales. Handb Clin Neurol. 2012;106:227\u201337.","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"6853_CR40","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","volume":"80","author":"JB Singh","year":"2016","unstructured":"Singh JB, Fedgchin M, Daly E, Xi L, Melman C, De Bruecker G, et al. Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization. Placebo-Controlled Study Biol Psychiatry. 2016;80(6):424\u201331.","journal-title":"Placebo-Controlled Study Biol Psychiatry"},{"issue":"4","key":"6853_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1182\/blood-2003-01-0019","volume":"102","author":"HR Salih","year":"2003","unstructured":"Salih HR, Antropius H, Gieseke F, Lutz SZ, Kanz L, Rammensee HG, et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood. 2003;102(4):1389\u201396.","journal-title":"Blood"},{"key":"6853_CR42","doi-asserted-by":"publisher","first-page":"108802","DOI":"10.1016\/j.clim.2021.108802","volume":"230","author":"MG Desimio","year":"2021","unstructured":"Desimio MG, Finocchi A, Di Matteo G, Di Cesare S, Giancotta C, Conti F, et al. Altered NK-cell compartment and dysfunctional NKG2D\/NKG2D-ligand axis in patients with ataxia-telangiectasia. Clin Immunol. 2021;230: 108802.","journal-title":"Clin Immunol"},{"issue":"3","key":"6853_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1007\/s00330-020-07209-6","volume":"31","author":"J Yoo","year":"2021","unstructured":"Yoo J, Kim SW, Lee DH, Bae JS, Cho EJ. Prognostic role of spleen volume measurement using computed tomography in patients with compensated chronic liver disease from hepatitis B viral infection. Eur Radiol. 2021;31(3):1432\u201342.","journal-title":"Eur Radiol"},{"issue":"2","key":"6853_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.immuni.2009.06.017","volume":"31","author":"B Zafirova","year":"2009","unstructured":"Zafirova B, Mandaric S, Antulov R, Krmpotic A, Jonsson H, Yokoyama WM, et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity. 2009;31(2):270\u201382.","journal-title":"Immunity"},{"key":"6853_CR45","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ebiom.2019.10.063","volume":"50","author":"W Nowak","year":"2019","unstructured":"Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena AR, Eberhardt N, et al. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019;50:290\u2013305.","journal-title":"EBioMedicine"},{"issue":"05","key":"6853_CR46","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2174\/1570159X13666150630171433","volume":"13","author":"B Bortolato","year":"2015","unstructured":"Bortolato B, Carvalho AF, Soczynsk JK, Perini GI, McIntyre RS. The involvement of TNF-\u03b1 in cognitive dysfunction associated with major depressive disorder: An opportunity for domain specific treatments. Curr Neuropharmacol. 2015;13(05):558\u201376.","journal-title":"Curr Neuropharmacol"},{"key":"6853_CR47","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1196\/annals.1321.010","volume":"1024","author":"IJ Elenkov","year":"2004","unstructured":"Elenkov IJ. Glucocorticoids and the Th1\/Th2 balance. Ann N Y Acad Sci. 2004;1024:138\u201346.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"6853_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000107420","volume":"14","author":"AM Myint","year":"2007","unstructured":"Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. NeuroImmunoModulation. 2007;14(2):65\u201371.","journal-title":"NeuroImmunoModulation"},{"issue":"1\u20133","key":"6853_CR49","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejphar.2009.03.076","volume":"612","author":"JY Guo","year":"2009","unstructured":"Guo JY, Li CY, Ruan YP, Sun M, Qi XL, Zhao BS, et al. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. Eur J Pharmacol. 2009;612(1\u20133):54\u201360.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"6853_CR50","doi-asserted-by":"publisher","first-page":"15703","DOI":"10.1038\/srep15703","volume":"5","author":"S-H Yang","year":"2015","unstructured":"Yang S-H, Kim J, Lee MJ, Kim Y. Abnormalities of plasma cytokines and spleen in senile APP\/PS1\/Tau transgenic mouse model. Scient Rep. 2015;5(1):15703.","journal-title":"Scient Rep."},{"issue":"2","key":"6853_CR51","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JAD-2010-100852","volume":"22","author":"S Subramanian","year":"2010","unstructured":"Subramanian S, Ayala P, Wadsworth TL, Harris CJ, Vandenbark AA, Quinn JF, et al. CCR6: A biomarker for Alzheimer\u2019s-like disease in a triple transgenic mouse model. J Alzheimers Dis. 2010;22(2):619\u201329.","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"6853_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3892\/ijmm.2017.2850","volume":"39","author":"H Zhan","year":"2017","unstructured":"Zhan H, Huang F, Yan F, Zhao Z, Zhang J, Cui T, et al. Alterations in splenic function and gene expression in mice with depressive-like behavior induced by exposure to corticosterone. Int J Mol Med. 2017;39(2):327\u201336.","journal-title":"Int J Mol Med"},{"key":"6853_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jad.2020.03.128","volume":"272","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chang L, Pu Y, Hashimoto K. Abnormal expression of colony stimulating factor 1 receptor (CSF1R) and transcription factor PU.1 (SPI1) in the spleen from patients with major psychiatric disorders: a role of brain-spleen axis. J Affect Disord. 2020;272:110\u20135.","journal-title":"J Affect Disord."},{"issue":"1","key":"6853_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41398-023-02564-6","volume":"13","author":"L Ma","year":"2023","unstructured":"Ma L, Wang L, Qu Y, Wan X, Hashimoto K. A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice. Transl Psychiatry. 2023;13(1):269.","journal-title":"Transl Psychiatry"},{"issue":"02","key":"6853_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1517\/14740338.6.2.199","volume":"06","author":"A Petroianu","year":"2007","unstructured":"Petroianu A. Drug-induced splenic enlargement. Expert Opin Drug Saf. 2007;06(02):199\u2013206.","journal-title":"Expert Opin Drug Saf"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06853-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06853-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06853-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:10:37Z","timestamp":1747041037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06853-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6853"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06853-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3938898\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Wuxi Mental Health Center (Batch Number: WXMHCIRB2020LLky039). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"477"}}